Patents
Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
04/2009
04/29/2009CN101416984A Bone-nourishing calcium tablet
04/29/2009CN100482278C Micro-cluster liquids and methods of making and using them
04/29/2009CN100482265C Medicine for treating facial neuritis and its preparing method
04/29/2009CN100482259C Chinese medicine for treating cervical spondylosis
04/29/2009CN100482257C Zuanshanfeng wind damp oil and its preparation method
04/29/2009CN100482256C Oral medicine liquid for treating rheumatic diseases and its preparing method
04/29/2009CN100482255C Medicine for treating gastropathy and gastrohelcosis and its preparation method
04/29/2009CN100482253C Preparation with antler gelatin and epimeddium for treating mammary gland hyperplasia and preparation method thereof
04/29/2009CN100482252C Medicinal composition for treating hepatitis B
04/29/2009CN100482247C Improved process for producing liver-care prepns.
04/29/2009CN100482244C Compound recipe medicine for treating apoplexy and its preparation method
04/29/2009CN100482242C Compound recipe medicine for curing insomnia and its preparation method
04/29/2009CN100482240C Compound preparation of Chinese traditional medicine for anticancer
04/29/2009CN100482239C Method and device for concentrating and stabilising conjugated oestrogens from the urine of mares
04/29/2009CN100482214C Blood circulation promoting and pain relieving bolus and its prepn
04/29/2009CN100482209C Coal-tar externally-applied gel for treating psoriasis and its preparation
04/29/2009CN100482104C Process for preparing lactic acid bacteria oral liquor
04/29/2009CN100482095C Injure preventing agent for forcedly changing feather and method for forcedly changing feather
04/29/2009CN100482085C Method for preparing soymilk powder contg. micron ginseng and antler etc. with tonifying-kidney and eliminating fatigue functions
04/28/2009US7524956 Hemisynthetic method and new compounds
04/28/2009US7524934 Human brain carboxypeptidase B antibodies
04/28/2009US7524815 Bovine or colostrum; milk, yogurt, curd, cheese, fermented milks, milk-based fermented products, ice creams, fermented cereal-based products, milk-based powders, infant formula, pet food; Osteoporosis, Paget's Disease, hypercalcemia, bone loss from arthritis, necrosis, or periodontal disease
04/28/2009US7524677 Mammalian cultured inner cell mass cell culture using a g1 cell as nuclear donor
04/28/2009US7524504 Anti-glycation hydrolysate of G. lucidum
04/28/2009US7524503 Antigens; vaccines; isolated peptide
04/28/2009US7524500 Method of stimulating stem cells
04/28/2009US7524489 Regeneration and repair of neural tissue using postpartum-derived cells
04/28/2009CA2446400C Osteoimplant and method for its manufacture
04/28/2009CA2283537C Vectors having enhanced expression, and methods of making and uses thereof
04/23/2009WO2009052394A2 Stem cell targeting of cancer, methods and compositions therefor
04/23/2009WO2009052323A2 Manufacture, compositions and uses of coagulationfactor viia modulator
04/23/2009WO2009052209A2 Isolation of stem cells and effective control of contamination
04/23/2009WO2009052132A1 Human amniotic fluid derived mesenchymal stem cells
04/23/2009WO2009051512A1 Lactobacteria strain consortium and a method for the production thereof based on a preparation used in the form of a biologically active additive or a starter for producing sour-milk products
04/23/2009WO2009051511A1 Method for producing a liquid or dried bifidobacteria concentrate or a starter
04/23/2009WO2009051510A1 Immobilised and lyophilised complex probiotic preparation and a method for the production thereof
04/23/2009WO2009051509A1 Milk culture medium for producing probiotic bacteria biomass
04/23/2009WO2009050742A1 Use of microvesicles (mvs) for preparing a medicament having adjuvant activity on endothelial cell transplantation, particularly in the treatment of diabetes by pancreatic islet transplantation, and related method
04/23/2009WO2009050677A2 Use of lactic bacteria for the prophylaxis and/or treatment of skin diseases
04/23/2009WO2009050535A1 Scar tissue treatment system
04/23/2009WO2009050390A2 Method for producing flu virus
04/23/2009WO2009049734A2 Cosmetic method for increasing the pigmentation of the skin using melanocyte precursor cells
04/23/2009WO2009028989A3 Overweight treatment method
04/23/2009WO2009028870A3 Composition for the diagnosis, prevention or treatment of diseases related to cells expressing il-8 or gro-alpha, comprising ucb-mscs
04/23/2009WO2009011924A9 Use of a chemotherapeutic agent in the preparation of a medicament for treating or ameliorating an adverse side effect associated with oncolytic viral therapy
04/23/2009WO2007138577A3 Methods of generating a neural tissue using muscle-derived cells
04/23/2009WO2007119240A3 Methods for bone regeneration using endothelial progenitor cell preparations
04/23/2009WO2007044902A3 Use of benzyl nicotinate for pain relief
04/23/2009WO2007041190A3 Polymer-based delivery system for immunotherapy of cancer
04/23/2009US20090105687 Scoring catheter with drug delivery membrane
04/23/2009US20090105120 Method for preparing tryptophan rich peptides
04/23/2009US20090104697 Method of differentiation of morula or inner cell mass cells and method of making lineage-defective embryonic stem cells
04/23/2009US20090104694 Isolation and transplantation of retinal stem cells
04/23/2009US20090104279 Use of pak inhibitor for the treatment of a joint disease
04/23/2009US20090104278 Food composition for recovery from fatigue
04/23/2009US20090104245 makes it possible to add viruses as biologically active agents into a biodegradable gel so that viruses do not loose their activity to infect and/or transfect cells; for controlled delivery of biologically active agents where said biodegradable carrier is a silica xerogel
04/23/2009US20090104233 IDENTIFICATION OF RESIDUES CRITICAL FOR THE FUNCTION OF THE VIBRIO CHOLERAE VIRULENCE REGULATOR ToxT BY SCANNING ALANINE MUTAGENESIS
04/23/2009US20090104230 Compositions and methods of using capsid protein from flaviviruses and pestiviruses
04/23/2009US20090104224 Modified vaccinia virus ankara for the vaccination of neonates
04/23/2009US20090104197 vWFA and/or ANT_IG Domain Containing Proteins
04/23/2009US20090104177 Peptides for inhibiting the interaction of protein kinase a and protein kinase a anchor proteins
04/23/2009US20090104170 Compositions and methods for treating hyperproliferative disorders
04/23/2009US20090104169 Pet food composition for skin photoprotection
04/23/2009US20090104168 Use of Specific Lactic Bacteria for the Preparation of Immunomodulating Compositions
04/23/2009US20090104167 Prophylactic/Ameliorating Agent for Menopausal Disorder and Functional Beverage/Food
04/23/2009US20090104166 Stimulating neurite outgrowth using tctex-1-related polypeptides
04/23/2009US20090104165 Transgenic strains of trichoderma and their use in biocontrol
04/23/2009US20090104164 Angiogenic cells from human placental perfusate
04/23/2009US20090104163 Immunomodulatory Properties of Multipotent Adult Progenitor Cells and Uses Thereof
04/23/2009US20090104162 Attenuated reoviruses for selection of cell populations
04/23/2009US20090104160 Mobilization of Stem Cells After Trauma and Methods Therefor
04/23/2009US20090104159 Vascular/Lymphatic Endothelial Cells
04/23/2009US20090104158 Non-Embryonic Totipotent Blastomere-Like Stem Cells And Methods Therefor
04/23/2009US20090104157 Utilization of bacteriophage to control bacterial contamination in fermentation processes
04/23/2009US20090104156 A recombinant virus into the genome of which is inserted DNA sequences coding for polypeptides of the early 6, the early E7, the late L1, the late L2 polypeptides of a papillomavirus ( HPV) and polypeptide having an immunostimulatory activity; antitumor/carcinogenic agents; gene therapy; uterus
04/23/2009US20090104154 Composition and method for killing of tumours
04/23/2009US20090104153 Method of eliciting immune response
04/23/2009US20090104117 Compositions and methods of use of targeting peptides against placenta and adipose tissues
04/23/2009US20090104114 Nanotherapeutic Colloidal Metal Compositions and Methods
04/23/2009US20090101599 Methods And Apparatus For Isolating Platelets From Blood
04/23/2009CA2737109A1 Scar tissue treatment system
04/23/2009CA2703034A1 Viral modification
04/23/2009CA2702970A1 Manufacture, compositions and uses of coagulation factor viia modulator
04/23/2009CA2702771A1 Cosmetic method for increasing the pigmentation of skin using melanocyte precursor cells
04/23/2009CA2702634A1 Compositions for treating multiple sclerosis
04/23/2009CA2702572A1 Tr1 cells, mesenchymal stem cells and uses thereof
04/23/2009CA2700288A1 Method for producing flu virus
04/22/2009EP2050762A2 Novel polypeptides and nucleic acids encoding the same
04/22/2009EP2050457A1 Method of removing abnormal prion from blood preparation
04/22/2009EP2050434A1 Moisturizing agent
04/22/2009EP2049136A1 Mitochondria-targeted antioxidants
04/22/2009EP2049130A1 Soft tissue filler composition comprising autologous dermis-derived cell culture product and hyaluronic acid
04/22/2009EP2049040A2 Whole blood-derived coagulum device for treating bone defects
04/22/2009EP2002842A9 Interleukin production regulator, pharmaceutical composition or food comprising the interleukin production regulator, and method for production of the interleukin production regulator
04/22/2009EP1567176B1 An anti-arrhythmic compound from king cobra venom and a process of purification thereof
04/22/2009EP1468014B1 Compositions and methods for WT1 specific immunotherapy
04/22/2009EP1424387B1 Method of extended culture for antigen-specific cytotoxic t lymphocytes
04/22/2009CN201223619Y Multifunctional integrated anaesthesia equipment for skin
04/22/2009CN101415817A Entrapped stem cells and uses thereof
04/22/2009CN101415458A Method to control ventricular rate in atrial fibrillation patients